About Dr. Brown
President & Medical Director
Dr. Serena-Lynn Brown is an internationally recognized M.D., Ph.D. with more than twenty years of experience as a clinical psychopharmacologist. She has published and presented over 100 scientific papers, books and book chapters, grand rounds, and is co-editor of the textbook The Role of Serotonin in Psychiatric Disorders. She has been selected to be in numerous Top Doctors and Best Doctors publications every year. She has received research grants from the National Institute of Mental Health, the American Suicide Foundation, the National Headache Foundation, etc.
Dr. Brown earned her Bachelors Degree from Reed College, her M.S., M.Phil. and Ph.D. from Yale University, her M.D. from University of Pittsburgh School of Medicine, and completed her medical training (internship, residency, and Biological Scientist Training Program Fellowship) at the Yale School of Medicine. Following her training, Dr. Brown spent nearly a decade as Director of the Psychopharmacology Clinic, Department of Psychiatry, Albert Einstein College of Medicine, where she remains on the clinical faculty. She is a diplomate of the American Board of Psychiatry and Neurology.
Her areas of specialization include: Mood Disorders (Depression, Bipolar Disorder); Anxiety Disorders (OCD, Panic Disorder, Trauma); Eating Disorders (Anorexia, Bulimia); Substance Use/Dual Diagnosis Disorders; and Attention Deficit Disorders. Dr. Brown works closely with other physicians (internists, neurologists, cardiologists, gastroenterologists, dermatologists, gynecologists, etc.) in the treatment of multisystem sequelae of psychiatric disorders such as sleep disorders, migraine, gastroenterological distress, chronic rash, pelvic pain, chronic neuropathic pain, and other concerns. A significant component of her practice includes diagnostic evaluations and second opinion assessments, working collaboratively with individual non-M.D. psychotherapists in treating patients. She has considerable experience with developing effective medication/treatment regimens for treatment-refractory patients living in the tri-state area and beyond.